It's pretty clear at this point that the latest class of Alzheimer's drugs — for all of the headlines, excitement and controversy it's caused — has limited effectiveness and potentially serious side effects, prompting researchers to look elsewhere.
Why it matters: The fact that we've found drugs with any effectiveness against Alzheimer's is a huge deal, but the hunt for the holy grail is still on.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,